Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:Hemerion Planning Phase 2 Trial at Mt. Sinai NY in 2022

I hope you're right, and you probably are, but the vagueness of the...

November 24, 2021

V.TLT

RE:RE:RE:RE:RE:RE:Hemerion Planning Phase 2 Trial at Mt. Sinai NY in 2022

What would be crazy would be if Hemerion accomplishes their aim of attaining...

November 24, 2021

V.TLT

RE:RE:Hemerion Planning Phase 2 Trial at Mt. Sinai NY in 2022

Hi Fred - I don't think this is about protectionism, it's about...

November 24, 2021

V.TLT

Hemerion Planning Phase 2 Trial at Mt. Sinai NY in 2022

In 2022, in collaboration with Hemerion Therapeutics, Drs. Yong and...

November 23, 2021

V.TLT

French start-up Hemerion conducting 5-ALA pdt trials of GBM

5-ALA and TLD1433 are the only two photosensitizers able to cross the blood...

November 23, 2021

T.PYR

RE:RE:RE:RE:Pyr CEO response to question regarding size of PFAS servicin

Holy Moly. To quote @arizona on ceo.ca - "PYR seems to have a habit of...

November 22, 2021

V.TLT

RE:FDA meeting now

I also registered but didn't have a chance to login. I sent the...

November 19, 2021

V.TLT

RE:RE:RE:Sedar entry at 845 am

I'm not sure. It seems that, for whatever reason, they are not going to...

November 18, 2021

V.TLT

RE:Sedar entry at 845 am

I found Project Number 3226110 in the OSC Bulletin of June 3, 2021&...

November 18, 2021

V.TLT

RE:RE:How do you rate TLD1433's POS, Dr. Madzarevic?

I think so too. It was a rhetorical question. newdaydawning wrote: I think...

November 18, 2021

V.TLT

RE:RE:How do you rate TLD1433's POS, Dr. Madzarevic?

I think Theralase is one of those "risky investments that in the...

November 18, 2021

V.TLT

How do you rate TLD1433's POS, Dr. Madzarevic?

Clinical Trials Success Marred with 90% of Disappointment Vera Madzarevic,...

November 18, 2021

V.TLT

Clinical Study Coordinator also hired

ANITA ANDOH Clinical Study Coordinator 8 years of experience as a...

November 15, 2021

V.TLT

RE:RE:RE:News out:Trikoka Gone and

She looks great. enriquesuave wrote: I like this girl already. Go Vera...

November 15, 2021

V.TLT

RE:RE:7th International A.M. Prokhorov Symposium on Biophotonics

That's very positive. "...the induction of apoptosis upon DNA...

November 14, 2021

V.TLT

7th International A.M. Prokhorov Symposium on Biophotonics

20 - 24 June 2022 St. Petersburg, Russia   Plenary Talk   ...

November 13, 2021

V.TLT

Theralase Has No Competition

Theralase is pioneering the use of transition metal complex based...

November 13, 2021

V.HPQ

Visit the EBH2 Website in a few days...

https://ebh2systems.com/ EBH2 is coming soon We are doing maintenance...

November 10, 2021

V.TLT

Gasser Group's New Approach to PDC Delivery to Cancer Cells

The Gasser Group at the Chimie Paris Tech led by Gilles Gasser is very...

November 8, 2021

V.TLT

Short Informative Article on Photodynamic Therapy for Cancer

It looks like Theralase is not the only one investigating X-Ray activation...

November 8, 2021